SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-039285
Filing Date
2021-07-29
Accepted
2021-07-29 16:01:47
Documents
22
Period of Report
2021-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144935-8k_lanternpharma.htm 8-K 21505
2 PRESS RELEASE DATED JULY 29, 2021 ANNOUNCING FINANCIAL RESULTS FOR QUARTER ENDED ea144935ex99-1_lanternpharma.htm EX-99.1 79543
3 PRESENTATION RELATING TO JULY 29, 2021 CONFERENCE CALL AND LIVE WEBCAST TO DISCU ea144935ex99-2_lanternpharma.htm EX-99.2 24387
4 GRAPHIC ex99-2_001.jpg GRAPHIC 180464
5 GRAPHIC ex99-2_002.jpg GRAPHIC 414311
6 GRAPHIC ex99-2_003.jpg GRAPHIC 175600
7 GRAPHIC ex99-2_004.jpg GRAPHIC 234020
8 GRAPHIC ex99-2_005.jpg GRAPHIC 180848
9 GRAPHIC ex99-2_006.jpg GRAPHIC 255772
10 GRAPHIC ex99-2_007.jpg GRAPHIC 175717
11 GRAPHIC ex99-2_008.jpg GRAPHIC 95656
12 GRAPHIC ex99-2_009.jpg GRAPHIC 76095
13 GRAPHIC ex99-2_010.jpg GRAPHIC 350936
14 GRAPHIC ex99-2_011.jpg GRAPHIC 318846
15 GRAPHIC ex99-2_012.jpg GRAPHIC 257937
16 GRAPHIC ex99-2_013.jpg GRAPHIC 121331
17 GRAPHIC ex99-2_014.jpg GRAPHIC 229157
18 GRAPHIC ex99-2_015.jpg GRAPHIC 220471
19 GRAPHIC ex99-2_016.jpg GRAPHIC 160324
20 GRAPHIC ex99-2_017.jpg GRAPHIC 244701
21 GRAPHIC ex99-2_018.jpg GRAPHIC 107476
22 GRAPHIC ex99-1_001.jpg GRAPHIC 9441
  Complete submission text file 0001213900-21-039285.txt   5360347
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 211127309
SIC: 2834 Pharmaceutical Preparations